| |
|
|
|
Evelo Biosciences Inc  
|
|
4.22 -0.13 (-0.03%) |
06-02 16:00 |
|
Open: |
4.4 |
Pre close: |
4.35 |
Target:
|
6.44
|
|
High: |
4.45 |
Low: |
4.18 |
Resistance:
|
5.51
6.45
|
|
Volume: |
97,644 |
Market Cap: |
136M |
Support:
|
4.00
3.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.48
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
4.62 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
4.69  |
Stochastic Oscillator |
%K(14,3):
|
17.93 |
|
MA(250): |
5.68 |
%D(3): |
22.87 |
|
Average Volume(K) |
3-Month: |
7098
|
52-Week |
High:
|
10.09 |
|
10-Days: |
7095 |
Low: |
3.01 |
|
RSI |
RSI(14):
|
43.96 |
Change(%): |
-35.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.747 |
Return on Equity (ttm) |
-111.5 |
Shares Out. (M) |
32.33 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.3 |
Shares Float (M) |
12.11 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.13 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
86.57 |
|
Forward EPS |
-2.780 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1780 |
|
Book Value (p.s.) |
1.220 |
EBITDA (p.s.) |
-2.689 |
P/E |
-1.54 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.46 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-73.50 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-44.21 |
P/CF |
-1.86 |
|
|
|
|
|
|
